Dentists in Lindstrom, MN Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Kindra L Bratteig, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 12245 Lindstrom Ln, Lindstrom, MN 55045 Phone: 651-257-4471 Fax: 651-257-2921 |
 Mr. Matthew Struve, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 30554 Park Street, Lindstrom, MN 55045 Phone: 651-257-4471 Fax: 257-257-2017 |
Lukas Gillett, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 12245 Lindstrom Ln, Lindstrom, MN 55045 Phone: 651-257-4471 |
Sean Patrick Goolsby, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 12745 N 1st Ave, Lindstrom, MN 55045 Phone: 651-257-2720 |
Mr. Michael A Hursh, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 30554 Park St, Lindstrom, MN 55045 Phone: 651-257-4471 Fax: 651-257-2017 |
News Archive
More efficient gene targeting improves prospects for gene therapy
The Nobel prize-winning MRC scientist Sir Aaron Klug and a team from an American company, Sangamo BioSciences, have announced a new way to target genes that may revolutionise medical research and pave the way for new treatments.
Medical experts propose six-point framework for safe production and use of Kava plant
Medical and scientific experts propose a global framework for the safe production and use of the medicinal plant Kava, including further clinical testing In Australia.
Also in Global Health news: Sleeping sickness; aid for Philippines; U.S., China in Africa; polio eradication in Afghanistan; Ethiopia famine
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
Major campaign victory will create safer environments for children with food allergies
About 11 million people - roughly 1-in-25 Americans - are now believed to be affected by one or more food allergies, a disease triggered by the ingestion or contact with certain foods that may cause life-threatening reactions, or anaphylaxis, according to a recent Food Allergy & Anaphylaxis Network nationwide survey.
Additional benefits of LAIAs over long-acting human insulin not been proven
It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This applies to adults as well as to children and adolescents. This is the result of the final report published by the Institute for Quality and Efficiency in Health Care (IQWiG) on 19 April 2010.
› Verified 6 days ago
Counselors
Dentists
Clinical Social Workers
Pharmacists
Psychologists
Occupational Therapists